Skip to content

Laparoscopic Sacropexy and Vaginal Natural Orifice Transluminal Endoscopic Surgery Shull Suspension Comparison Trial

Laparoscopic Supracervical Hysterectomy With Cervicosacropexy and Vaginally Assisted NOTES Hysterectomy With Uterosacral Ligament Suspension (Shull Technique): a Randomized Multicentric Prospective Comparison Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05856201
Acronym
V-PULSE
Enrollment
90
Registered
2023-05-12
Start date
2023-05-31
Completion date
2024-12-31
Last updated
2023-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Brief summary

This is a prospective, randomized multicenter study whose objective is to compare two surgical techniques routinely used at our center for the correction of pelvic organ prolapse (laparoscopic cervicosacropexis versus colposuspension sec. Shull using v-NOTES).

Detailed description

patients with pelvic organ prolapse with a stage greater than or equal to stage 2 for the apical compartment who are candidates for surgical correction will be randomized and assigned to one of two treatment groups. The aim is to compare the anatomical, surgical and anesthesiological outcomes between these two surgical techniques, both of which are commonly used in clinical practice for the correction of this type of prolapse.

Interventions

PROCEDURELaparoscopic cervicosacropexy

The first step consists of a supracervical hysterectomy with morcellation. Anterior and posterior dissection of the vesicovaginal and rectovaginal space. Placing a flexible blade or a Breisky blade in the vagina which is manipulated by the assistant in order to improve exposure of the tissue planes. The retroperitoneum will then be opened from sacral promontory to cervix with the incision just medial to the uterosacral ligament. A low-weight preshaped Y-shaped polypropylene mesh will be secured to the anterior and posterior vagina with four to six separated absorbable 2.0 polyglactin sutures and two nonabsorbable 2.0 prolene sutures can be placed at the level of the remaining cervix. The mesh will be attached to the sacral promontory using two or three nonabsorbable monofilament 2.0 prolene suture. The retroperitoneal space will be closed with continuous 2.0 polyglactin suture or barbed 2.0 absorbable suture material.

PROCEDUREShull technique via V-NOTES

Using a cold-bladed scalpel, pericervical colpotomy and subsequent opening of the Douglas and vesico-uterine space is performed. The following step is forcipressure and section of uterosacral ligaments bilaterally with cold blade scissors and ligation in Polysorb 0. A v-PATH® wall retractor is placed, after insertion of three trocars. Total hysterectomy is then performed by standard V-NOTES technique. After transperitoneal visualization of the ureters bilaterally, the peritoneum is incised between the ureters and the uterosacral ligaments, which are thus bilaterally isolated, and three points in polydioxanone 2/0 are placed per side. The v-PATH wall retractor is then removed. Finally the suspension of the vaginal vault at the uterosacral ligaments is made according to Shull technique. Eventual fascial corrections of concomitant anterior or posterior defects will be associated if needed.

Sponsors

Azienda Ospedaliero, Universitaria Pisana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The 6-week examination and review will be performed by the surgeon with all study data and future visits completed by blinded co-authors (Different surgeon or Urogynecology fellows) who will be unaware of group allocation.

Intervention model description

We will perform a interventional, no profit, prospective, randomized 1:1 multicentre, controlled trial with participating tertiary referral hospital centers in Italy, to compare the laparoscopic cervicosacropexy (CSP) and Shull technique via V-NOTES (VNS) in the management of apical prolapse.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* consecutive women referred to one of the participating centers with symptomatic stage 2 or greater (point C≥ -1 pelvic organ prolapse quantification POP-Q) apical prolapse (uterovaginal) with or without anterior and posterior compartment prolapse will be eligible for inclusion (Criteria for which patients in clinical practice are candidates for one of the two interventions under study)

Exclusion criteria

* age \<18 years, BMI \> 30, * previous hysterectomy, * inability to comprehend questionnaires, to give informed consent and to return for review, * unable to undergo general anesthesia, * prior laparoscopic prolapse repair or vaginal mesh prolapse procedure, * desire for future pregnancy or current pregnancy diagnosis * severe respiratory comorbidity, * ASA III patients, * need for concomitant anti-incontinence procedure.

Design outcomes

Primary

MeasureTime frameDescription
operating timeintraoperativefrom skin/vaginal incision to end of skin/vaginal suture
post-operative painat 4 hours post-operativeVAS (visual analogic scale, from 0 (minimum), to 10 (maximum pain))
time to mobilization with standingimmediately post-operativeTime it takes the patient to mobilize to standing independently
hospital stayimmediately post-operativehours of post-operative stay
patient satisfactionat 6 weeksassessed by P-QoL (prolapse quality of life) validated questionnaire
sexual functionat 6 weeksassessed by FSFI (female sexual function index) questionnaire
recurrence of prolapse in apical compartmentat 6 weeks and 3 months;POP-Q (Pelvic Organ Prolapse Quantification system) C point measure
recurrence of prolapse in the anterior and posterior compartments when presentat 3 months;
postoperative complicationsfrom surgery to 3 motnhs follow.upassessed using Clavien-Dindo classification
anesthesiological parametersintraoperativeEnd tidal CO2 (carbon dioxide) assessement

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026